2care4 Generics ApS: Financial statements 2025
CVR: 36960566
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. That is a decrease of 9.9% compared with the year before. Equity in the 2025 report amounted to DKK 49,944,000. The solvency ratio was 43.4%. The company had 29 employees in the financial year.
- Gross Profit
- DKK 52,415,000
- Profit/Loss
- DKK 11,207,000
- Equity
- DKK 49,944,000
- Total Assets
- DKK 115,193,000
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 52.4 mio. | 11.2 mio. | 49.9 mio. | 29 |
| 2024 | - | 58.2 mio. | 17.2 mio. | 78.7 mio. | 20 |
| 2023 | - | 73.4 mio. | 31.6 mio. | 86.5 mio. | 15 |
| 2022 | - | 75.7 mio. | 34.6 mio. | 74.2 mio. | 12 |
| 2021 | - | 55.9 mio. | 29.1 mio. | 44.6 mio. | 15 |
Official annual report
How creditworthy is 2care4 Generics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 16, 2025, Henrik Bisgaard Jensen has left the board of directors of 2care4 Generics ApS.
As of December 1, 2025, Thomas Hjarsbæk Rasmussen has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has won the tender "Amgros 2026 1.1212.a" issued by Amgros I/S worth 44,707,811 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.1303.b" issued by Amgros I/S worth 4,100,779 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 1.603.a" issued by Amgros I/S worth 7,867,813 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.703.b" issued by Amgros I/S worth 66,045,550 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 1.700.a" issued by Amgros I/S worth 245,033,539 DKK.
2care4 Generics ApS has published its annual report for 2024. Gross profit came to DKK 58,190,000, and the net result was DKK 17,193,000.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.